Loading clinical trials...
Loading clinical trials...
Poor case management, pharmacokinetic variability and on-going transmission have fostered the drug-resistant tuberculosis (DR-TB) epidemic leading to a global estimated number of \>500,000 new multidr...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Namibia
Collaborators
NCT01212003 · Mycobacterium Infections, Tuberculosis, Multidrug-Resistant, and more
NCT02354014 · Tuberculosis, Multidrug-Resistant
NCT05824871 · Rifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)
NCT03828201 · Tuberculosis, Multidrug-Resistant
NCT05871489 · Tuberculosis, Multidrug-Resistant, HIV
University of Namibia
Windhoek
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions